These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2561143)

  • 1. The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin.
    Tio RA; Heiligers JP; de Langen CD; van Gilst WH; König W; Saxena PR; Wesseling H
    J Hypertens Suppl; 1989 Dec; 7(6):S296-7. PubMed ID: 2561143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.
    Barbe F; Su JB; Guyene TT; Crozatier B; Ménard J; Hittinger L
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H1985-92. PubMed ID: 8764248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen-2)27) rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1694-701. PubMed ID: 9422816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
    Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
    Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
    Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):194-200. PubMed ID: 7477443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
    Lindsey CJ; Bendhack LM; Paiva AC
    J Hypertens Suppl; 1987 Jul; 5(2):S71-6. PubMed ID: 2821209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of bradykinin and the ischemic isolated rat heart.
    Tio RA; van Gilst WH; Rett K; Wolters K; Dietze GJ; Wesseling H
    Horm Metab Res Suppl; 1990; 22():85-9. PubMed ID: 2167866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalaprilat, an angiotensin-converting enzyme inhibitor, enhances functional preservation during long-term cardiac preservation. Possible involvement of bradykinin and PKC.
    Yang X; Zhu Q; Fong J; Gu X; Hicks GL; Bishop SP; Wang T
    J Mol Cell Cardiol; 1996 Jul; 28(7):1445-52. PubMed ID: 8841932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous bradykinins in the acute depressor effect of angiotensin converting enzyme inhibitor captopril--assessed by a competitive antagonist of bradykinin.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    Clin Exp Hypertens A; 1989; 11(1):35-43. PubMed ID: 2653669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
    Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
    Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
    Muller AF; Gardiner SM; Compton AM; Bennett T
    Clin Sci (Lond); 1990 Oct; 79(4):393-401. PubMed ID: 2171862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits.
    Whorlow SL; Angus JA; Wright CE
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):951-61. PubMed ID: 9869501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.